News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Amy J. Grizzle, PharmD

Articles by Amy J. Grizzle, PharmD

Reasons Provided by Prescribers When Overriding Drug-Drug Interaction Alerts

ByAmy J. Grizzle, PharmD,Maysaa H. Mahmood, MS,Yu Ko, MS,John E. Murphy, PharmD,Edward P. Armstrong, PharmD,Grant H. Skrepnek, PhD,William N. Jones, MS,Gregory P. Schepers, PharmD,W. Paul Nichol, MD,Antoun Houranieh, PhD,Donna C. Dare, PharmD,Christopher T. Hoey, PharmD,Daniel C. Malone, PhD

October 1st 2007

Latest Updated Articles

Reasons Provided by Prescribers When Overriding Drug-Drug Interaction Alerts
Published: October 1st 2007 | Updated:

Trending on AJMC

FDA Approves First-in-Class Optune Pax Device for Pancreatic Cancer

Bipartisan Break Up Big Medicine Act Targets Vertical Integration in Health Care

Contributor: American Patients vs Foreign Governments—A Tale of 2 Value Sets

3-Year EPCORE NHL-1 Data Published Showing 53% Have Deep, Durable Remission

Real-World Evidence Supports Switch to Next-Generation BTK Inhibitor for CLL: A Q&A With Margaret Krackeler, MD